The dexamethasone suppression test in the clinical setting

D. L. Evans, G. B. Burnett, Charles Nemeroff

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

The authors administered the dexamethasone suppression test (DST) to 47 inpatients on a clinical, nonresearch psychiatric unit who had been diagnosed according to DSM-III. Of the 30 patients with major depression, 23 (77%) exhibited nonsuppression (serum cortisol concentrations greater than 5 μg/dl); only 1 of the 17 patients with other diagnoses and depressive symptoms exhibited nonsuppression. There was no difference in the rate of nonsuppression between the patients with subgroups of major depression, but those with major depression and psychosis had significantly higher postdexamethasone cortisol levels than those with major depression with and without melancholia and those with diagnoses other than major depression.

Original languageEnglish
Pages (from-to)586-589
Number of pages4
JournalAmerican Journal of Psychiatry
Volume140
Issue number5
StatePublished - Jan 1 1983
Externally publishedYes

Fingerprint

Dexamethasone
Depression
Hydrocortisone
Depressive Disorder
Diagnostic and Statistical Manual of Mental Disorders
Psychotic Disorders
Psychiatry
Inpatients
Serum

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

The dexamethasone suppression test in the clinical setting. / Evans, D. L.; Burnett, G. B.; Nemeroff, Charles.

In: American Journal of Psychiatry, Vol. 140, No. 5, 01.01.1983, p. 586-589.

Research output: Contribution to journalArticle

Evans, D. L. ; Burnett, G. B. ; Nemeroff, Charles. / The dexamethasone suppression test in the clinical setting. In: American Journal of Psychiatry. 1983 ; Vol. 140, No. 5. pp. 586-589.
@article{3669059b0e064dce97fea1f8b984f51d,
title = "The dexamethasone suppression test in the clinical setting",
abstract = "The authors administered the dexamethasone suppression test (DST) to 47 inpatients on a clinical, nonresearch psychiatric unit who had been diagnosed according to DSM-III. Of the 30 patients with major depression, 23 (77{\%}) exhibited nonsuppression (serum cortisol concentrations greater than 5 μg/dl); only 1 of the 17 patients with other diagnoses and depressive symptoms exhibited nonsuppression. There was no difference in the rate of nonsuppression between the patients with subgroups of major depression, but those with major depression and psychosis had significantly higher postdexamethasone cortisol levels than those with major depression with and without melancholia and those with diagnoses other than major depression.",
author = "Evans, {D. L.} and Burnett, {G. B.} and Charles Nemeroff",
year = "1983",
month = "1",
day = "1",
language = "English",
volume = "140",
pages = "586--589",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "5",

}

TY - JOUR

T1 - The dexamethasone suppression test in the clinical setting

AU - Evans, D. L.

AU - Burnett, G. B.

AU - Nemeroff, Charles

PY - 1983/1/1

Y1 - 1983/1/1

N2 - The authors administered the dexamethasone suppression test (DST) to 47 inpatients on a clinical, nonresearch psychiatric unit who had been diagnosed according to DSM-III. Of the 30 patients with major depression, 23 (77%) exhibited nonsuppression (serum cortisol concentrations greater than 5 μg/dl); only 1 of the 17 patients with other diagnoses and depressive symptoms exhibited nonsuppression. There was no difference in the rate of nonsuppression between the patients with subgroups of major depression, but those with major depression and psychosis had significantly higher postdexamethasone cortisol levels than those with major depression with and without melancholia and those with diagnoses other than major depression.

AB - The authors administered the dexamethasone suppression test (DST) to 47 inpatients on a clinical, nonresearch psychiatric unit who had been diagnosed according to DSM-III. Of the 30 patients with major depression, 23 (77%) exhibited nonsuppression (serum cortisol concentrations greater than 5 μg/dl); only 1 of the 17 patients with other diagnoses and depressive symptoms exhibited nonsuppression. There was no difference in the rate of nonsuppression between the patients with subgroups of major depression, but those with major depression and psychosis had significantly higher postdexamethasone cortisol levels than those with major depression with and without melancholia and those with diagnoses other than major depression.

UR - http://www.scopus.com/inward/record.url?scp=0020584784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020584784&partnerID=8YFLogxK

M3 - Article

VL - 140

SP - 586

EP - 589

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 5

ER -